First Time Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 138.01 USD 0.1% Market Closed
Updated: Apr 26, 2024
Section:
 

Relative Value

The Relative Value of one DXCM stock under the Base Case scenario is 48.2 USD. Compared to the current market price of 138.01 USD, Dexcom Inc is Overvalued by 65%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXCM Relative Value
Base Case
48.2 USD
Overvaluation 65%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

14.7
P/S
P/S
Price to Sales
14.7
vs History
60
vs Industry
10
Median 3Y
15.2
Median 5Y
15.2
Industry
2.4
Forward
12.1
More Details
98.2
P/E
P/E
Price to Earnings
98.2
vs History
53
vs Industry
4
Median 3Y
119.5
Median 5Y
119.5
Industry
22.8
Forward
77.3
More Details
71.1
P/OCF
P/OCF
Price to OCF
71.1
vs History
50
vs Industry
4
Median 3Y
65.3
Median 5Y
71.5
Industry
15.1
More Details
56.2
P/FCFE
P/FCFE
Price to FCFE
56.2
vs History
66
vs Industry
11
Median 3Y
148.8
Median 5Y
151.4
Industry
23.1
More Details
25.7
P/B
P/B
Price to Book Value
25.7
vs History
15
vs Industry
2
Median 3Y
20.7
Median 5Y
20.7
Industry
2.2
More Details
14.6
EV/S
EV/S
Enterprise Value to Sales
14.6
vs History
57
vs Industry
10
Median 3Y
14.8
Median 5Y
14.8
Industry
2.4
Forward
12
More Details
23
EV/GP
EV/GP
Enterprise Value to Gross Profit
23
vs History
52
vs Industry
9
Median 3Y
22.7
Median 5Y
22.8
Industry
5.1
More Details
66.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
66.2
vs History
69
vs Industry
3
Median 3Y
80.8
Median 5Y
81.4
Industry
12.3
Forward
42.7
More Details
86.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
86.2
vs History
71
vs Industry
3
Median 3Y
113.4
Median 5Y
110.6
Industry
16.8
Forward
59.9
More Details
70.8
EV/OCF
EV/OCF
Enterprise Value to OCF
70.8
vs History
53
vs Industry
4
Median 3Y
63.6
Median 5Y
70.7
Industry
14.7
More Details
103.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
103.5
vs History
84
vs Industry
4
Median 3Y
139.6
Median 5Y
160.6
Industry
19.3
More Details
16.2
EV/IC
EV/IC
Enterprise Value to IC
16.2
vs History
73
vs Industry
4
Median 3Y
16.6
Median 5Y
21.4
Industry
1.9
More Details

Multiples Across Competitors

DXCM Competitors Multiples
Dexcom Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Dexcom Inc
NASDAQ:DXCM
53.2B USD 14.7 98.2 66.2 86.2
US
Abbott Laboratories
NYSE:ABT
185.3B USD 4.6 32.9 19.4 28.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
131.5B USD 18 66.1 54.7 68.2
US
Stryker Corp
NYSE:SYK
128.2B USD 6.3 40.5 25.2 31.2
US
Boston Scientific Corp
NYSE:BSX
107.4B USD 7.5 68.4 31.8 47.4
IE
Medtronic PLC
NYSE:MDT
105.4B USD 3.3 25.1 13.4 19
US
Becton Dickinson and Co
NYSE:BDX
66.6B USD 3.4 54.6 18.3 38.8
DE
Siemens Healthineers AG
XETRA:SHL
58.4B EUR 2.7 38.4 18.5 31.1
US
Edwards Lifesciences Corp
NYSE:EW
52.9B USD 8.8 37.7 27.3 29.6
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
346.5B CNY 10.1 30.6 26.5 26.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
40.6B USD 11.1 48.1 33.8 37.4

See Also

Summary
DXCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXCM stock valuation using valuation multiples.
Wall Street Estimates
DXCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.